Results 101 to 110 of about 21,002 (228)

Education in Pharmacoeconomics: An International Multidisciplinary View

There is a global need for more training in pharmacoeconomics. Pharmacoeconomics is a relatively new discipline that draws from other more established disciplines; hence, multidisciplinary collaboration is recommended.
Lieven Annemans, Karen L. Rascati, Michael F. Drummond, Peter G. Davey   +3 more
core  

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9336-9345, October 2026.
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Sungho Bea, Hyesung Lee, Young Min Cho, You‐Jung Choi, Ju‐Young Shin, Katsiaryna Bykov   +5 more
wiley   +1 more source

Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age?

Decision-making ...
Michael Drummond, Mark Sculpher
core  

Data-Driven Vaccine Clinical Trial Design Features and Associated Progress Patterns: An Analysis of 1618 Clinical Trials from 2012 to 2022

Vaccines
Background/Objectives: Vaccine clinical trials face high costs, long timelines, and variable progression rates, yet systematic evidence linking trial design features to progression outcomes remains limited.
Siyang Chan, Dachuang Zhou, Di Zhang, Yuting Xia, Wenxi Tang   +4 more
doaj   +1 more source

Effective Utilization of Pharmacoeconomics for Decision Makers

Increased worldwide cost consciousness with regard to healthcare spending has resulted in a greater reliance of health systems on pharmacoeconomics as a tool for obtaining optimal value, attaining better outcomes, and controlling spending.
Ron Corey, Judith D. Bentkover
core  

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry

Complexity
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system.
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh   +7 more
doaj   +1 more source

Pharmacoeconomics and its importance in psychiatry

, 2010
The budget for health is limited in Turkey and other developing countries. In order to use the sources as good as possible, for rational drug use, it is necessary to consider economomical outcomes besides efficacy and safety.

core  

Pharmaco-Economics of Aspirin Therapy

Pakistan Armed Forces Medical Journal, 2005
Aspirin as an antiplatelet agent is the most commonly used drug in therapeutics. It is inexpensive while on the contrary other antiplatelet drugs are very expensive.
Mahmud Ahmad Akhtar
doaj  

Is There a Role for Pharmacoeconomics in Developing Countries?

Decision-making, Drug-cost, Formularies, Pharmacoeconomics.
Babar Zaheer-Ud-Din, Shane Scahill
core  

Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer

Frontiers in Medicine
ObjectiveThis study aimed to evaluate the cost-effectiveness of two Chinese patent medicines, including Kang Ai injection and Shenqi Fuzheng injection with each combined with platinum-based chemotherapy as the first-line treatment for patients with ...
Junjie Zhu, Junjie Zhu, Lei Tian, Lei Tian   +3 more
doaj   +1 more source